您当前的位置:
首页 >
文章列表页 >
Exploring the pathogenesis and treatment of ocular myasthenia gravis based on the theory of xuanfu
Theoretical discussion | 更新时间:2025-08-04
    • Exploring the pathogenesis and treatment of ocular myasthenia gravis based on the theory of xuanfu

    • In the field of autoimmune diseases, experts have explored the pathogenesis and treatment methods of ocular myasthenia gravis based on the Xuanfu theory, providing new ideas for treatment.
    • Modern Chinese Clinical Medicine   Vol. 32, Issue 4, Pages: 59-62(2025)
    • DOI:10.3969/j.issn.2095-6606.2025.04.012    

      CLC: R276.7
    • Received:27 August 2024

      Published:30 July 2025

    移动端阅览

  • HUANG Ruqing, WU Peng. Exploring the pathogenesis and treatment of ocular myasthenia gravis based on the theory of xuanfu[J]. Modern chinese clinical medicine, 2025, 32(4): 59-62. DOI: 10.3969/j.issn.2095-6606.2025.04.012.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Discussion on the differentiation and treatment of hypertension combined with cognitive impairment based on the theory of xuanfu-shenji
Treatment of post-stroke hemiplegia from the perspective of "internal deficiency leading to susceptibility to wind attacks"
To explore the pathogenesis, outcome and treatment principles of malignant tumor based on the theory of latent oncotoxin
Syndrome differentiation and treatment of recurrent urinary calculi based on combination of disease and syndrome
Application of "body, qi and spirit" theory in hyperthyroidism

Related Author

LIU Ziwang
ZHAO Yansong
ZHANG Meng
HU Tianshi
WU Rouyan
MA Pei
LI Zhigeng
JIA Yuejin

Related Institution

Dongzhimen Hospital, Beijing University of Chinese Medicine
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine
Third Affiliated Hospital, Beijing University of Chinese Medicine
Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences
0